On the recordApril 28, 2021
The brand firms are actually filing these petitions, subsequently found to be almost always meritorious, and that results in the delay of lower cost generic drugs being brought to the market.
Source
congress.govThe brand firms are actually filing these petitions, subsequently found to be almost always meritorious, and that results in the delay of lower cost generic drugs being brought to the market.
Jeffries highlights how brand firms misuse petitions to delay generic drug entry.
Share
More from Hakeem Jeffries
Fighting for an affordable America — that's what unites Democrats all across the country.